Connect with us

Technology

As City Buses Turn Electric, IDTechEx Asks What Awaits the Electric Coach Market

Published

on

BOSTON, July 1, 2024 /PRNewswire/ — Electric buses are booming, with sales growing in Europe, America, India, and other key regions. Transport operators have shown themselves keen to electrify urban transport and cut greenhouse gas emissions. As emissions regulations tighten, city buses are likely to be all-electric within the next few years. IDTechEx’s report, “Electric and Fuel Cell Buses 2025-2045: Markets, Players, Technologies and Forecasts“, shows that over half of all city bus sales in Europe in 2023 were electric (battery and fuel cell) and that some regions are well ahead of the EU’s target for 100% of new city buses to be zero emission by 2035. However, in the coach segment, only around 1% of sales were electric across the same period, so what is driving the excellent growth in the city segment, and will it be replicated for coaches?

City buses are the perfect candidates for electrification

Buses were one of the first transportation sectors to demonstrate that they could be completely electrified. In China, sales began at pace in the early 2010s and reached a peak in 2016 when almost 140,000 electric buses were sold in a single year. While the sales figures have since declined and then plateaued – the overall bus fleet is now over 77% electric. With over 3 quarters of buses electric, these are not pilot projects or early successes but established incumbent technology. Electric buses now have well over a decade of use, transporting millions of people safely and efficiently. But what are the unique aspects of city bus transport that have allowed electrification to outpace other bus sectors?

Predictability: City buses, by their nature, follow predetermined routes with set schedules every day that they are in service. For electric buses, this means that routes can be optimized such that range anxiety is effectively removed. Compare this to a private passenger car, where the daily mileage might vary substantially, and routes longer than the range of the vehicle may be desired.

Opportunity charging: City buses are typically confined to a single metropolitan zone, and to be useful, transit services must stop regularly for passengers to embark/disembark. This presents a perfect chance for opportunity charging, where either overhead pantographs or wireless charging can quickly top up the batteries. This allows operators to potentially use a smaller Li-ion battery pack yet achieve the same range. This brings cost and weight savings.

Concentration of infrastructure: Buses are typically parked overnight in depots, and many buses may use a single site. This allows for the concentration of infrastructure, as building out grid capacity for a single site may allow the charging of an entire fleet of buses. Buses typically operate during the day, meaning they have a much longer period to charge. Thus, lower-level trickle charging can be used rather than grid-intensive fast charging – this also slows the battery degradation. When the busses are operating the daily routes, this infrastructure can then be utilized by other vehicles such as public charging or eLCV fleets. This generates revenue for the bus operator and recoups some of the investment in the infrastructure.

In summary, electric city buses are here to stay. They have demonstrated that they can operate in a wide range of conditions – with buses in operation from Northern China to Southern Spain. With correct route optimization and clever infrastructure utilization, they can comfortably operate most routes operators require.

What about coaches?

While city bus sales have turned increasingly electric, the coach market, by contrast, is stagnant and almost entirely diesel. IDTechEx research has assessed some of the challenges that hold back electrification, both technical and economic.

Range: One of the larger technical hurdles to overcome is range. Although energy density improvements have allowed onboard battery storage to increase, electric vehicles still have shorter ranges than their ICE counterparts. As battery pack size increases, weight and volume become a challenge. Improvements in energy density can help overcome this, but current state-of-the-art packs are insufficient to provide adequate range. Coach journeys are typically much longer and travel interurban, intercity, and even international routes. As such, the limited range is a much greater challenge than that of a city bus, which may have a much lower daily required mileage.

Charging infrastructure: These coaches will typically leave built-up areas behind and travel long distances on highways without stopping. As recharging will be required, the necessary highway infrastructure needs to be put in place for coaches to recharge en route. Unlike city buses, which can charge slowly overnight, these coaches are likely to need fast charging to avoid passengers having to wait multiple hours in a remote service station, which would increase journey times and reduce customer satisfaction. The non-concentrated nature of coach travel (fewer coaches will travel to a much wider range of destinations) means that more charging infrastructure will need to be developed.

Funding: Currently, battery electric buses are about twice as expensive as a comparable diesel bus. While large metropolitan transport operators may be able to afford the investment, regional coach transport operators are often much smaller entities and thus struggle to absorb the increased costs associated with electrifying. Government support is also less prominent. The UK’s successful ZEBRA (Zero Emissions Buses Regional Areas) has contributed to the strong growth in electric sales, but it explicitly excludes coaches from any subsidy support.

What options are left in this challenging environment? Fuel cell buses, with their greater range and quicker refueling, are considered alternatives to battery electric buses by some, but challenges with hydrogen production and distribution remain. Increases in Li-ion cell density will translate into greater ranges for fully electric buses, but to what extent can these overcome the challenges of long-haul travel? What is the regulatory outlook for coach travel compared with city buses? IDTechEx explores these questions and more in its in-depth review of the topic, “Electric and Fuel Cell Buses 2025-2045: Markets, Players, Technologies and Forecasts”.

To find out more about this IDTechEx report, including downloadable sample pages, please visit www.IDTechEx.com/Buses.

For the full portfolio of electric vehicles market research available from IDTechEx, please see www.IDTechEx.com/Research/EV.

About IDTechEx 
 
IDTechEx provides trusted independent research on emerging technologies and their markets. Since 1999, we have been helping our clients to understand new technologies, their supply chains, market requirements, opportunities and forecasts. For more information, contact research@IDTechEx.com or visit www.IDTechEx.com

Media Contact: 

Charlotte Martin 
Subscriptions Marketing Manager 
press@IDTechEx.com 
+44(0)1223 812300 

Social Media Links: 
 
X: https://www.twitter.com/IDTechEx 
LinkedIn: https://www.linkedin.com/company/idtechex/ 

Photo: https://mma.prnewswire.com/media/2451918/IDTechEx_City_Buses.jpg
Logo: https://mma.prnewswire.com/media/478371/IDTechEx_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/as-city-buses-turn-electric-idtechex-asks-what-awaits-the-electric-coach-market-302186918.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Macrogen Consortium win tender for National Bio Big Data Project

Published

on

By

Illumina is proud to be selected as sequencing technology partner to the Macrogen Consortium.

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ — Macrogen a global healthcare company that specializes in precision medicine and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today that they are honoured to support the National Bio Big Data project by sequencing and analysing 145,952 Korean genomes.

The National Bio Big Data Project project has been running in Korea as a pilot project since 2020. During this period about 20,000 genomes were analysed, 10,000 of these including people with a rare disease. The ultimate goal is to enable precision medicine by building a reference genome for about 770,000 Koreans by 2028 and a total of 1 million by 2032.  

“Being a part of this step change to improving public health in Korea through the voluntary collection and analysis of genomic, clinical and life record information from the general public, is paramount to ensure precision medicine becomes a standard of care for all Koreans,” said Changhoon Kim, CEO Macrogen.

“Illumina is pleased to be a part of the Korean bio industry ecosystem and to participate in such an important national project. We look forward to contributing to Korea by bringing our expertise and lessons learned from our direct involvement in leading pop gen projects around the world,” said Robert McBride, General Manager of Illumina Korea.

People across the globe have very similar genes but a small number of variants between populations can impact health. For example, some variants are associated closely with particular diseases such as cystic fibrous.[1]These variants can present differently in populations and have a significant impact on how individuals respond to medicines and treatments. Therefore, it is beneficial for Koreans to have information available that is unique to them.

Worldwide, the number of pop gen projects is expanding rapidly, including the UK, Japan, Singapore, Qatar, the United Arab Emirates, and Nigeria.

“Population genome projects are growing worldwide with many programs reaching significant milestones. But despite this inequity remains with the majority of genome datasets being of European descent. This means we have a lot of information how to develop drugs for European populations but this doesn’t translate in any meaningful way to other nationalities, said Robert McBride.

Population genomics provides a platform for industry engagement and investment, specifically in the pharmaceutical, biotechnology, and data sectors. By integrating large, diverse data sets and using advanced computing technology (such as artificial intelligence or machine learning), health systems and partners are optimally positioned to unlock the power of the genome even further, while improving quality of life and care and fostering economic growth.

“Precision medicine is changing how diseases are treated and this benefits everyone. For patients, treatments often work better when decisions are based around an individual’s genome, for drug companies it can reduce cost of development and for governments there are long term savings related to less waste and healthier patients,” said Changhoon Kim.

References

[1] https://www.genome.gov/about-genomics/educational-resources/fact-sheets/human-genomic-variation#:~:text=How%20do%20peoples’%20genomes%20vary,person%20responds%20to%20certain%20medications.

About Macrogen

Macrogen is a global genetic service provider, partnered with over 18,000 scientists in 150+ countries, and with more than 20 years of experience in the industry.

Established in 1997, from the Genome Medical Research Institute of Seoul National University, Macrogen has become a major service provider and consulting agent for government agencies, universities and research institutes around the world.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube

About the Consortium

Macrogen Consortium members include the following companies: DNA Link, Theragen Bio, and CG Invites

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/macrogen-consortium-win-tender-for-national-bio-big-data-project-302335981.html

SOURCE Illumina

Continue Reading

Technology

As 2025 IRS Mileage Rate Hits 70 Cents, Expert Warns: Ditch Risky Apps for Secure Paper Tracking

Published

on

By

Gig economy expert Ed Ryder warns against the risks of mileage tracking apps, and advocates using paper-based tracking methods instead. He introduces The Big Mileage Form, a secure alternative developed over two years to meet the specific needs of food delivery gig workers. Ryder highlights recent tech failures, like the July 2024 global IT outage, to underscore the vulnerabilities of digital solutions. The press release also mentions Ryder’s significant mileage deduction using his form and directs readers to GigCoach.net for additional resources, including a consumer tutorial to drive better food delivery outcomes and a gig coach training program.

PHILADELPHIA, Dec. 22, 2024 /PRNewswire-PRWeb/ — As the IRS announces a standard mileage rate of 70 cents per mile for 2025, gig economy expert Ed Ryder, who has completed over 10,000 deliveries with his own car using major food delivery platforms, urges fellow gig workers to reconsider their mileage tracking methods. While acknowledging the convenience of digital solutions, Ryder advocates for a return to secure, paper-based tracking to protect valuable mileage deductions.

With the mileage rate at 70 cents, accurate tracking is crucial for gig workers and small business owners. Mileage apps seem convenient, but they risk data loss from outages, glitches, and cyber attacks. Many overlook these significant dangers.

“With the mileage rate increasing to 70 cents, accurate tracking is more crucial than ever for gig workers and small business owners,” says Ryder, creator of The Big Mileage Form. “While mileage tracking apps seem convenient, they come with significant risks that many overlook. Network outages, app glitches, and cyber attacks can jeopardize months of data.”

Ryder points to the July 2024 global IT outage as a prime example of technology’s vulnerabilities. “A faulty software update caused mass airline disruptions and impacted other industries, catching major corporations off guard. This incident highlights that even in our digital age, software isn’t infallible. For me, I simply won’t trust mileage tracking apps with my most important tax deduction.”

To address these concerns, Ryder developed a comprehensive, paper-based solution. “I spent two years perfecting The Big Mileage Form, tailoring it to the specific needs of food delivery gig workers,” he explains. “At 11×17 inches, it provides ample space for detailed record-keeping and, crucially, it’s immune to software glitches, data breaches, and ransomware attacks.”

Ryder’s meticulous paper-based record-keeping resulted in a mileage deduction exceeding $19,000 on his 2023 federal taxes. “All my business-related miles are thoroughly documented on paper. I’m fully prepared to defend this deduction in case of an audit. This level of confidence is what I aim to provide other gig workers.”

“In today’s digital age, sometimes the most secure solution is the simplest one,” Ryder concludes. “My form not only ensures data security but also prepares users for potential IRS audits. It’s time to reconsider the old-fashioned, but reliable pen-and-paper method.”

For those interested in learning more about effective mileage tracking and other aspects of gig work, Ryder offers valuable resources on GigCoach.net. These include a tutorial for consumers titled ‘Fair Deal Delivery,’ which provides insights on how to improve food delivery outcomes. Additionally, experienced food delivery couriers can explore Ryder’s gig coach training program. Visit GigCoach.net to access these resources and learn more about The Big Mileage Form.

Media Contact

Ed Ryder, Match Experiment LLC, 1 484-493-8740, hello@ideamaned.com, gigcoach.net

View original content to download multimedia:https://www.prweb.com/releases/as-2025-irs-mileage-rate-hits-70-cents-expert-warns-ditch-risky-apps-for-secure-paper-tracking-302337779.html

SOURCE Gig economy expert Ed Ryder

Continue Reading

Technology

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Ascension Health Customers Whose Data May Have Been Compromised

Published

on

By

NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ — The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Ascension Health (“Ascension”). Ascension learned of suspicious activity on or about May 8, 2024. To join this case, go HERE.

About Ascension Health

Ascension is a prominent non-profit health system in the nation and operates under Catholic principles.

What happened?

On or about May 8, 2024, Ascension detected unauthorized activity in its computer systems. Ascension initiated an investigation, which included retaining consulting cybersecurity experts and notifying the FBI. The investigation determined that between May 7 and 8, 2024, a cybercriminal accessed files containing personal information about Ascension’s patients and employees. This information included names, medical records, payment details, insurance information, government identification numbers, and other personal data such as dates of birth and addresses. Approximately 6 million individuals have been affected by this data breach.

How can I protect my personal data?

If you receive a data breach notification, you must guard against possible misuse of your personal information, including identity theft and fraud, by regularly reviewing your account statements and monitoring your credit reports for suspicious or unauthorized activity. Additionally, you should consider legal options for mitigating such risks.

Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for customers whose sensitive personal and patient data may have been compromised by the Ascension data breach.

For more information, please contact:

Marc H. Edelson, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492
Email: medelson@edelson-law.com
Web:  www.edelson-law.com 

About Edelson Lechtzin LLP
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and catastrophic injuries.

This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so counsel does not represent you unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing now. Your ability to share in any potential future recovery does not depend on serving as lead plaintiff.

View original content to download multimedia:https://www.prnewswire.com/news-releases/data-breach-alert-edelson-lechtzin-llp-is-investigating-claims-on-behalf-of-ascension-health-customers-whose-data-may-have-been-compromised-302337976.html

SOURCE Edelson Lechtzin LLP

Continue Reading

Trending